publication venue for
- Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program. 29:527-532. 2019
- A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme. 24:144-149. 2014
- Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens. 16:347-355. 2006
- MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma. 10:259-264. 2000
- A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A27-35 and Melan-A26-35. 10:16-25. 2000
- Erratum: A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: Differential immunogenicity of Melan-A27-35 and Melan-A26-35 (Melanoma Research (2000) 10:1 (21)). 10:193. 2000